Studies found conflicting results on efficacy of uterotonic agents used to prevent and treat
uterine atony, the most common cause of postpartum hemorrhage. Uterine EMG can be used to
objectively assess myometrial contractility and, consequently, efficacy of different
uterotonics.
The investigators are planning a single-center, randomized, open-label trial to compare
uterine EMG parameters in women receiving oxytocin vs. those receiving carbetocin after
cesarean delivery.